CMV (CYTOMEGALOVIRUS) IGG ANTIBODIES, SERUM

The CMV (Cytomegalovirus) IgG Antibodies, Serum Test is a blood test that detects Immunoglobulin G (IgG) antibodies against Cytomegalovirus (CMV), a common member of the herpesvirus family. The test helps determine whether a person has been previously infected with CMV and has developed an immune response.

CMV infection is extremely common worldwide, and many people become infected during childhood or adulthood without experiencing noticeable symptoms. Once infected, the virus remains dormant (inactive) in the body and may reactivate if the immune system becomes weakened.

Although CMV infection is usually mild in healthy individuals, it can cause serious complications in pregnant women, newborn babies, organ transplant recipients, people living with HIV/AIDS, and other immunocompromised individuals. During pregnancy, a primary CMV infection can be transmitted to the unborn baby, potentially causing congenital CMV infection, hearing loss, vision problems, developmental delays, or neurological complications.

The CMV IgG Antibodies Test is frequently used during pregnancy evaluation, infertility investigations, pre-transplant screening, and immune status assessment. It is often performed together with the CMV IgM Antibody Test to help distinguish between past infection and recent or active infection. In certain cases, CMV PCR or CMV DNA testing may also be recommended for further evaluation.

Benefits of the Test

• Detects CMV IgG antibodies indicating previous exposure
• Helps assess immunity against Cytomegalovirus
• Supports pregnancy and prenatal infection screening
• Assists in evaluating transplant recipients and immunocompromised patients
• Complements CMV IgM and molecular testing
• Requires only a peripheral blood sample
• Supports early clinical decision-making

Why Doctors Recommend This Test

Doctors may recommend this test for individuals with:

• Pregnancy planning or prenatal screening
• Suspected CMV infection
• Organ transplant evaluation
• HIV/AIDS or weakened immune system
• Unexplained prolonged fever
• Mononucleosis-like illness
• Infertility evaluation
• Neonatal infection assessment
• TORCH profile screening
• Pre-transplant donor or recipient testing

Preparation Before Test

Sample Required

• Peripheral venous blood sample (Serum)

Preparation Guidelines

• No fasting is required.
• Continue prescribed medications unless advised otherwise by your physician.
• Inform your healthcare provider if you are pregnant, immunocompromised, or have undergone an organ transplant.
• Follow laboratory instructions before sample collection.

Reporting Time

Results are generally available within 1–3 working days, depending on the laboratory methodology.

Who Should Take This Test?

This test is recommended for:

• Pregnant women or women planning pregnancy
• Individuals with suspected CMV infection
• Organ transplant donors and recipients
• Immunocompromised patients
• Patients undergoing TORCH screening
• Individuals with prolonged unexplained fever
• Patients referred by obstetricians, infectious disease specialists, pediatricians, transplant specialists, or physicians

Clinical Significance

A positive CMV IgG antibody result may indicate:

• Previous Cytomegalovirus infection
• Past exposure to CMV
• Long-term immunity following infection
• Latent CMV infection

Common symptoms of primary CMV infection may include:

• Fever
• Fatigue
• Sore throat
• Swollen lymph nodes
• Muscle aches
• Mild hepatitis
• Mononucleosis-like illness

A positive CMV IgG result does not necessarily indicate an active infection. It usually reflects previous exposure and the presence of long-term antibodies. To determine whether the infection is recent or active, doctors often recommend CMV IgM testing, IgG avidity testing, or CMV DNA PCR depending on the clinical situation. Results should always be interpreted in conjunction with the patient's symptoms, pregnancy status, immune status, and other laboratory findings.